Does RTOG 9802 change practice with respect to newly diagnosed low-grade glioma?

Journal of Clinical Oncology

Volumn 31, Issue 5, 2013, Pages 652-653

  Chamberlain, Marc C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; GLIOMA; HUMAN; LETTER; LONG TERM CARE; PATIENT CARE; PRIORITY JOURNAL; PUBLICATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY, ADJUVANT; GLIOMA; HUMANS; SUPRATENTORIAL NEOPLASMS;

EID: 84875439232     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.46.7969     Document Type: Letter

References (8)

1. Shaw EG, Wang M, Coons SW, et al: Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: Initial results of RTOG 9802. J Clin Oncol 30: 3065-3070, 2012
2. van den Bent MJ, Afra D, de Witte O, et al: Long term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial. Lancet 366: 985-990, 2005 (Pubitemid 41323034)
3. Karim AB, Afra D, Cornu P, et al: Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council Study BRO4 - An interim analysis. Int J Radiat Oncol Biol Phys 52: 316-324, 2002 (Pubitemid 34170840)
4. Shaw E, Arusell R, Scheithauer B, et al: Prospective randomized trial of lowversus high-dose radiation therapy in adults with supratentorial low-grade glioma: Initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20: 2267-2276, 2002 (Pubitemid 34441653)
5. Pignatti F, van den Bent M, Curran D, et al: Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20: 2076-2084, 2002 (Pubitemid 34408798)
6. Intergroup Radiation Therapy Oncology Group Trial 9402, Cairncross G, Berkey B, et al: Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Oncology Group Trial 9402. J Clin Oncol 24: 2707-2714, 2006 (Pubitemid 46630566)
7. van den Bent MJ, Carpentier AF, Brandes AA, et al: Adjuvant procarbazine, lomustine, and vincristine improves progression free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A randomized European Organization for Research and Treatment of Cancer Phase III trial. J Clin Oncol 24: 2715-2722, 2006 (Pubitemid 46630567)
8. van den Bent MJ, Hoang-Xuan K, Brandes AA, et al: Long-term follow-up results of EORTC 26951: A randomized phase III study on adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors (AOD). J Clin Oncol 30:5s, 2012 (suppl; abstr 2)